Mode
Text Size
Log in / Sign up

IBD-related neuroimaging shows brain alterations in emotional networks with distinguishable phenotypes for Crohn's and ulcerative colitisBrain scans show different emotional patterns in Crohn's and ulcerative colitis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that current IBD neuroimaging findings are descriptive and require large-sample validation before clinical application.

This bibliometric analysis and systematic scoping review evaluates 175 articles regarding IBD-related neuroimaging literature sourced from the Web of Science Core Collection and Scopus databases. The review scope encompasses inflammatory bowel disease, Crohn's disease, and ulcerative colitis without reporting specific medication interventions or patient populations.

Key synthesized findings indicate that brain alterations predominantly localize within an emotional and interoceptive network, specifically the anterior cingulate cortex, insula, and amygdala. Abnormalities generally associate with abdominal pain, anxiety, and depression. Furthermore, Crohn's disease and ulcerative colitis appear to exhibit distinguishable neuroimaging phenotypes. No specific effect sizes or absolute numbers were reported for these outcomes.

The authors note significant limitations including small sample sizes, methodological heterogeneity, lack of standardization, and the fact that direct comparative studies remain limited. Safety data and adverse events were not reported. The review does not provide causal conclusions or specific clinical recommendations due to these constraints.

Future efforts should prioritize large-sample multicenter validation, longitudinal designs capable of testing mechanistic hypotheses, and multimodal data integration to transition the field from descriptive observations toward clinically meaningful applications.

People with inflammatory bowel disease often feel pain and anxiety. New research looks at brain scans to understand why. A review of 175 articles examined brain images from patients with Crohn's disease and ulcerative colitis. These are serious conditions that cause chronic gut inflammation. The study looked at how the brain processes feelings and pain in these patients.

The analysis found that brain changes mostly happen in areas that handle emotions and body sensations. These include the anterior cingulate cortex, the insula, and the amygdala. Abnormalities in these regions are linked to abdominal pain, anxiety, and depression. This explains why many patients struggle with mental health issues alongside their gut problems.

Importantly, Crohn's disease and ulcerative colitis appear to show different brain patterns. Each condition seems to affect the brain in its own unique way. However, the review noted that the number of studies was small. Methods varied widely across the research. Direct comparisons between the two diseases remain limited. Future work needs larger groups of people and longer studies to confirm these findings.

What this means for you:
Brain scans reveal distinct emotional patterns for Crohn's and ulcerative colitis.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundInflammatory bowel disease (IBD) is recognized as a prototypical disorder of brain-gut interaction. Although neuroimaging research in this field has advanced rapidly in recent years, the findings remain fragmented across multiple disciplines, and a systematic integration of the literature is lacking.ObjectiveThis study presents the first integrated bibliometric analysis and literature review to map the landscape and evolving trends of neuroimaging research in IBD over the past two decades and to identify the knowledge base and research frontiers.MethodsWe conducted a systematic search of the Web of Science Core Collection and Scopus databases for IBD-related neuroimaging literature published between January 2000 and January 2026. Following the PRISMA guidelines, two independent reviewers screened titles, abstracts, and full texts. A total of 175 articles met the inclusion criteria. Data were extracted on study characteristics, neuroimaging modalities, and clinical findings. For the synthesis, we employed a dual approach: (1) a bibliometric analysis using VOSviewer, Biblioshiny, and CiteSpace to map publication trends, collaboration networks, and research hotspots; and (2) a structured literature review across five predefined dimensions: technical modalities, brain region–symptom associations, subtype differences, mechanistic pathways, and clinical translation.ResultsThe systematic search and selection process identified 175 articles for final synthesis. The field has entered a phase of rapid expansion since 2021, with China and the United States as core contributing countries. Emerging frontiers include the “brain-gut axis” and the “default mode network.” The literature synthesis indicates that: (1) brain alterations are predominantly localized within an emotional and interoceptive network (anterior cingulate cortex, insula, and amygdala), with abnormalities generally associated with abdominal pain, anxiety, and depression; and (2) Crohn’s disease and ulcerative colitis appear to exhibit distinguishable neuroimaging phenotypes, though direct comparative studies remain limited.ConclusionThis study systematically clarifies the knowledge structure of the IBD neuroimaging field, demonstrates that the available neuroimaging evidence is consistent with the brain-gut axis as a central theoretical framework, and identifies subtype-specific neural characteristics. Future efforts should prioritize large-sample multicenter validation, longitudinal designs capable of testing mechanistic hypotheses, and multimodal data integration to transition the field from descriptive observations toward clinically meaningful applications,though substantial barriers—including small sample sizes, methodological heterogeneity, and lack of standardization—must first be overcome.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.